Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 6/20 | 0.55 |
| ▸ | BLM | P54132 | 5/20 | 0.55 |
| ▸ | PTGS1 | P23219 | 4/20 | 0.55 |
| ▸ | LMNA | P02545 | 4/20 | 0.55 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.55 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.55 |
| ▸ | AKR1C3 | P42330 | 8/20 | 0.53 |
| ▸ | AKR1C2 | P52895 | 8/20 | 0.53 |
| ▸ | PTGS2 | P35354 | 5/20 | 0.52 |
| ▸ | TSHR | P16473 | 4/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.51 |
| ▸ | CDC42 | P60953 | 1/20 | 0.51 |
| ▸ | RAC1 | P63000 | 1/20 | 0.51 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.51 |
| ▸ | POLB | P06746 | 3/20 | 0.51 |
| ▸ | MAPT | P10636 | 3/20 | 0.51 |
| ▸ | NFKB1 | P19838 | 3/20 | 0.51 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL32660739 | 1.00 | TDP1 (0.55) | TDP1BLMPTGS1LMNANR1I2 | |
| SCHEMBL28183228 | 0.98 | TDP1 (0.53) | TDP1BLMPTGS1LMNANR1I2 | |
| SCHEMBL1891624 | 0.91 | AKR1C3 (0.54) | TDP1BLMPTGS1LMNANR1I2 | |
| Methylhydrazine SCHEMBL11546869 | 0.91 | TDP1 (0.51) | TDP1BLMPTGS1LMNANR1I2 | |
| SCHEMBL28165575 | 0.85 | TDP1 (0.52) | TDP1BLMPTGS1LMNANR1I2 | |
| SCHEMBL4066823 | 0.84 | PTGS1 (0.62) | PTGS1AKR1C3AKR1C2PTGS2TSHR | |
| SCHEMBL30526268 | 0.84 | AKR1C3 (0.54) | PTGS1AKR1C3AKR1C2PTGS2TSHR | |
| SCHEMBL11218780 | 0.84 | AKR1C3 (0.54) | PTGS1AKR1C3AKR1C2PTGS2TSHR | |
| SCHEMBL4129677 | 0.82 | AKR1C3 (0.47) | PTGS1LMNAAKR1C3AKR1C2PTGS2 | |
| SCHEMBL1679626 | 0.82 | PTGS2 (0.49) | PTGS1AKR1C3AKR1C2PTGS2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 627 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3869192-B1 | METHOD FOR QUANTITATIVE DETECTION OF VARIOUS METABOLITES IN BIOLOGICAL SAMPLE | HUMAN METABOLOMICS INST INC (CN) | 2026-05-13 | — | — | EP | claimed |
| US-20250258146-A1 | QUANTITATIVE DETECTION METHOD OF MULTIPLE METABOLITES IN BIOLOGICAL SAMPLE AND METABOLIC CHIP | HUMAN METABOLOMICS INSTITUTE INC. (CN) | 2025-08-14 | — | — | US | claimed |
| CN-120137523-A | Water-based self-lubricating natural gas hydrate resistant coating | 中国科学院广州能源研究所 | 2025-06-13 | — | — | CN | claimed |
| CN-119971127-A | Sodium hyaluronate gel compound for wound repair and preparation process thereof | 金华市景迪医疗用品有限公司 | 2025-05-13 | — | — | CN | claimed |
| CN-119931549-A | Modified chitosan-modified carbon nanotube covalent bonding agent and preparation method and application thereof | 东华大学 | 2025-05-06 | — | — | CN | claimed |
| WO-2025077935-A1 | WATER-BASED SELF-LUBRICATING COATING RESISTANT TO NATURAL GAS HYDRATES | 中国科学院广州能源研究所 | 2025-04-17 | — | — | WO | claimed |
| CN-119454623-B | Allyl pregnane sustained-release medicament and preparation method thereof | 宁波科瑞特动物药业有限公司 | 2025-04-11 | — | — | CN | claimed |
| WO-2025051247-A1 | LABELING METHOD FOR CHARACTERIZING CELL-CELL CONTACT AND USE THEREOF | 中国科学院基础医学与肿瘤研究所(筹) | 2025-03-13 | — | — | WO | claimed |
| CN-119454623-A | Allyl pregnane sustained-release medicament and preparation method thereof | 宁波科瑞特动物药业有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-116463852-B | Wash-and-wear skin-friendly polyester fabric and preparation method thereof | 杭州晨昊纺织整理有限公司 | 2024-10-01 | — | — | CN | claimed |
| CN-101203278-A | Ultraviolet protection | MERCK PATENT GMBH (DE) | 2008-06-18 | — | — | CN | claimed |
| CN-101163659-A | Antioxidants | MERCK PATENT GMBH (DE) | 2008-04-16 | — | — | CN | claimed |
| EP-1871339-A1 | UV PROTECTION | Merck Patent GmbH (DE) | 2008-01-02 | — | — | EP | claimed |
| EP-1871735-A1 | ANTIOXIDANTS | Merck Patent GmbH (DE) | 2008-01-02 | — | — | EP | claimed |
| WO-2007127459-A2 | RAPID PEPTIDOGLYCAN-BASED ASSAY FOR DETECTION OF BACTERIAL CONTAMINATION OF PLATELETS | IMMUNETICS, INC. (US) | 2007-11-08 | — | — | WO | claimed |
| US-20060269982-A1 | Rapid peptidoglycan-based assay for detection of bacterial contamination of platelets | IMMUNETICS, INC. (US) | 2006-11-30 | — | — | US | claimed |
| WO-2006111233-A1 | ANTIOXIDANTS | MERCK PATENT GMBH (DE) | 2006-10-26 | — | — | WO | claimed |
| WO-2006111234-A1 | UV PROTECTION | MERCK PATENT GMBH (DE) | 2006-10-26 | — | — | WO | claimed |
| US-20030199566-A1 | Phenolic acid derivatives and composition for preventing or treating blood lipid level-related diseases comprising the same | BIONUTRIGEN CO., LTD. (KR) | 2003-10-23 | — | — | US | claimed |
| EP-0357565-A2 | New process for the synthesis of the levodopa | MINISTERO DELL' UNIVERSITA' E DELLA RICERCA SCIENTIFICA E TECNOLOGICA (IT) | 1990-03-07 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030199566-A1 | Phenolic acid derivatives and composition for preventing or treating blood lipid level-related diseases comprising the same | NCEH1, HMGCR, DBH | TDP1 3030/4885BLM 4277/4885PTGS1 563/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.